🇺🇸 FDA
Pipeline program

TL-895, TL-895, TL-895, TL-895 matching placebo, TL-895, TL-895

TL-895-201

Phase 2 small_molecule active

Quick answer

TL-895, TL-895, TL-895, TL-895 matching placebo, TL-895, TL-895 for Indolent Systemic Mastocytosis is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).

Program details

Company
Lacuna Pharma Pty Ltd
Indication
Indolent Systemic Mastocytosis
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials